| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $16.06B | $19.79B | $17.44B |
| YoY Revenue Growth % | -18.8% | +13.5% | — |
| Gross Profit | $3.00B | $4.06B | — |
| Gross Margin % | 18.7% | 20.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$74.5M | $961.6M | $1.04B |
| Operating Margin % | -0.5% | 4.9% | 6.0% |
| Net Income (GAAP) | $0 | $0 | $0 |
| EBITDA (Normalized) | $503.7M | $1.67B | $1.67B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$1.23B | $2.18B | $7.14B |
| Capital Expenditures (CapEx) | $722.7M | $890.6M | $785.0M |
| Free Cash Flow (FCF) | -$1.95B | $1.29B | $6.36B |
| FCF Margin % | -12.2% | 6.5% | 36.4% |
| Return on Invested Capital (ROIC %) | -2.1% | 42.2% | 6.5% |
| Cash & Short-Term Equivalents | $8.11B | $9.03B | — |
| Total Debt (Short + Long Term) | $471.8M | $1.12B | $4.90B |
| Total Stockholders' Equity | $10.38B | $9.71B | $10.05B |